Sartorius Stedim Biotech Aktie
202,10
EUR
-2,90
EUR
-1,41
%
202,30
EUR
-3,60
EUR
-1,75
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
16.04.25 | Sartorius Stedim Biotech Market-Perform | Bernstein Research | |
29.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
24.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
22.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
03.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
27.06.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
Werbung
|
|||
18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group |
Werbung
Werbung